SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-04-000010
Filing Date
2004-05-07
Accepted
2004-05-07 15:52:08
Documents
10
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 03/31/04 10Q ligand030410q.htm 10-Q 344498
2 EXHIBIT 10.273 ex10-273.txt EX-10 30281
3 EXHIBIT 10.274 ex10-274.txt EX-10 99344
4 EXHIBIT 10.275 ex10-275.txt EX-10 89191
5 EXHIBIT 10.276 ex10-276.txt EX-10 69236
6 EXHIBIT 10.277 ex10-277.txt EX-10 30318
7 EXHIBIT 31.1 ex31-1.txt EX-31 3169
8 EXHIBIT 31.2 ex31-2.txt EX-31 3161
9 EXHIBIT 32.1 ex32-1.txt EX-32 1834
10 EXHIBIT 32.2 ex32-2.txt EX-32 1818
  Complete submission text file 0000886163-04-000010.txt   675350
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 04789201
SIC: 2834 Pharmaceutical Preparations